| Product NDC: | 62856-350 |
| Proprietary Name: | LUSEDRA |
| Non Proprietary Name: | fospropofol disodium |
| Active Ingredient(s): | 35 mg/mL & nbsp; fospropofol disodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 62856-350 |
| Labeler Name: | Eisai, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022244 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081212 |
| Package NDC: | 62856-350-58 |
| Package Description: | 8 VIAL in 1 TRAY (62856-350-58) > 30 mL in 1 VIAL |
| NDC Code | 62856-350-58 |
| Proprietary Name | LUSEDRA |
| Package Description | 8 VIAL in 1 TRAY (62856-350-58) > 30 mL in 1 VIAL |
| Product NDC | 62856-350 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fospropofol disodium |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20081212 |
| Marketing Category Name | NDA |
| Labeler Name | Eisai, Inc |
| Substance Name | FOSPROPOFOL DISODIUM |
| Strength Number | 35 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |